1. Home
  2. THFF vs PCRX Comparison

THFF vs PCRX Comparison

Compare THFF & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Corporation Indiana

THFF

First Financial Corporation Indiana

N/A

Current Price

$76.07

Market Cap

881.8M

Sector

Finance

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$36.44

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THFF
PCRX
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
881.8M
1.0B
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
THFF
PCRX
Price
$76.07
$36.44
Analyst Decision
Hold
Hold
Analyst Count
4
9
Target Price
★ $85.33
$33.57
AVG Volume (30 Days)
132.0K
★ 2.5M
Earning Date
10-27-2026
11-09-2026
Dividend Yield
★ 2.92%
N/A
EPS Growth
67.00
★ 107.44
EPS
★ 5.89
0.89
Revenue
N/A
★ $541,533,000.00
Revenue This Year
$10.67
$3.84
Revenue Next Year
$16.17
$4.73
P/E Ratio
★ $13.45
$191.58
Revenue Growth
N/A
★ 26.04
52 Week Low
$54.76
$18.80
52 Week High
$84.17
$36.67

Technical Indicators

Market Signals
Indicator
THFF
PCRX
Relative Strength Index (RSI) 50.47 83.16
Support Level $74.32 $24.59
Resistance Level $78.70 $36.45
Average True Range (ATR) 1.96 0.06
MACD 0.18 -0.39
Stochastic Oscillator 33.52 86.67

Price Performance

Historical Comparison
THFF
PCRX

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: